May 20, 2019
The daily brief: 20 May 2019
From left to right: director Mikko Myllylahti, jury members Gaëlle Mareschin and Mathilde Henrotin, as well as producer Emilia Haukka.
All the daily Finnish business news that works: KONE, Eficode, Verman, Airport College International and Finnish film The Woodcutter Story make headlines.
Finnish company KONE will supply escalators and lifts in Tel Aviv, Eficode and Verman have made corporate acquisitions, Airport College International finds a partner in Hong Kong and Mikko Myllylahti’s screenplay The Woodcutter Story wins in Cannes.
Mikko Myllylahti’s screenplay for his debut feature film, The Woodcutter Story (Metsurin tarina), has won the Next Step Award at Cannes Critics’ Week. The mythical dark comedy follows an optimistic woodcutter who loses everything when a dark force enters his hometown in Finnish Lapland. The film is produced by Aamu Film Company and is to be shot during the winter of 2020 in Northern Finland.
KONE will deliver 106 escalators and 63 lifts for the Red Line of Tel Aviv Light Rail in Israel. The contract also includes 16 years of maintenance services. The Red Line will serve 34 stations and be part of an ambitious new mass transit system in the Tel Aviv metropolitan area.
Finland-based Airport College International has signed a memorandum of understanding (MOU) with Jardin Aviation Academy operating out of Hong Kong. The two parties aim to collaborate on aviation training programmes in Hong Kong, Macau and mainland China.
Finnish development and operations company Eficode has acquired Praqma, a development and operations consultancy firm operating in Sweden, Norway and Denmark. The joined companies will have nearly 300 software experts in the Nordics, the Netherlands and Germany. Praqma reported a turnover of 5.5 million euros last year.
Verman, a Finnish family company focusing on health and wellbeing products, has acquired Biosym, a Danish producer of vitamins, mineral preparations and natural remedies. The acquisition will strengthen Verman’s position in the Nordics. Biosym will continue its operations as before, but as a wholly owned subsidiary of Verman.